[ Price : $8.95]
FDA accepts for priority review an Eisai NDA for its in-house developed anticancer agent lenvatinib mesylate as a treatment for pr...[ Price : $8.95]
Federal Register Notice: FDA seeks comments on an information collection on the labeling of natural rubber latex condoms.[ Price : $8.95]
Federal Register Notice: FDA releases a guidance on distinguishing device recalls from medical device enhancements.[ Price : $8.95]
FDA approves two NDAs ahead of their user fee goal dates for treating idiopathic pulmonary fibrosis.[ Price : $8.95]
FDA National Center for Toxicological Research scientists say they have spent 25 years studying the effects of drugs on childrens ...[ Price : $8.95]
Dietary supplement GMP consultant Rick Soltero says companies are starting to understand that being GMP-compliant is a marketing c...[ Price : $8.95]
Newly-created Melbourne Laboratories names former CDER Office of Generic Drugs acting deputy director Robert W. Pollock as its fou...